Showing results (11-20 of 35) with videos related to
Sort By:
Pageof 4
Journal of Health & Life Sciences Law|March 18, 2009
Enforcement related to off-label marketing and use of drugs and devices: where have we been and where are we going?John N Joseph, David Deaton, Houman Ehsan, et al.Journal of Health & Life Sciences Law|March 18, 2009
Physician ownership and use of in-office advanced diagnostic imaging equipment: are IDTF standards a meaningful response to overutilization, quality, and costs?Markus P CickaJournal of Health & Life Sciences Law|July 10, 2008
Tort reform by regulation: FDA prescription drug labeling rules and preemption of state tort claimsMichael P MorelandJournal of Health & Life Sciences Law|July 10, 2008
Scientific misconduct in researchMelissa L MarkeyJournal of Health & Life Sciences Law|July 10, 2008
Executive Order 13,422, OMB's good guidance practices, and implications for health rulemaking and guidanceMarci Dale HarrisJournal of Health & Life Sciences Law|August 23, 2008
Limited provider panels: their promise and problems in an individual health insurance marketWilliam H PitsenbergerJournal of Health & Life Sciences Law|August 14, 2009
Preparing for quality-based payments: trends and legal barriers to successful implementationCatherine A Martin, Tamara R TenneyJournal of Health & Life Sciences Law|August 14, 2009
Changing expectations for board oversight of healthcare quality: the emerging paradigmTracy E Miller, Valerie L GutmannJournal of Health & Life Sciences Law|August 14, 2009
Using electronic health information for pharmacovigilance: the promise and the pitfallsKristen RosatiJournal of Health & Life Sciences Law|November 14, 2008
Patient-tailored medicine, Part one: the impact of race and genetics on medicineJeffrey P Braff, Biswajit Chatterjee, Meredith Hochman, et al.Pageof 4